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Primaryhyperparathyroidism (PHPT)hasbecomeanasymptomaticdiseaseintheWesternworldwiththeintroduction ofroutine
calcium screening. However, the same phenomenon is not observed in India. We have now systematically reviewed the status of
PHPTin India. Whilethere is a paucity ofliterature on PHPTfrom India when compared to Westerncountries, someinformation
can be gleaned upon. Most patients present with symptomatic disease whereas very few are screen-detected cases (bone disease
77%, renal disease 36%, and 5.6% asymptomatic). Mean calcium, parathyroid hormone (PTH), and alkaline phosphate levels are
high while Vitamin D levels are low. The average parathyroid gland weight is large and the majority being parathyroid adenomas
(89.1%). Hungry bone syndrome (HBS) is common in the postoperative period. The disease-related mortality rate is 7.4%,
recurrence 4.16%, and persistent disease 2.17%. We suggest that dedicated eﬀorts are needed to pick up asymptomatic disease
in India by methods like incorporating calcium estimation in the routine health check-up programs.
1.Introduction
Primary hyperparathyroidism (PHPT) is a disease charac-
terized by hypercalcemia due to autonomous production
of parathyroid hormone (PTH). PHPT is present in 1%
of the adult population, and its incidence increases to 2%
after the age of 55 years in Western series [1]. With the
advent of multichannel biochemical screening in the 1970s,
the incidence of PHPT increased around the world. Subse-
quently, the clinical entity of asymptomatic hyperparathy-
roidism was recognized [2]. There are striking discrepancies
around the world with respect to incidence, symptoms, and
complicationsofPHPT.Indevelopingcountries,particularly
India, PHPT is still an uncommonly diagnosed, overtly
symptomatic disease of “bones, stones, abdominal groans,
and psychic moans.” This may be because of the fact that, in
India, screening of the healthy population for hypercalcemia
is nota routine practiceand there is limited access tomedical
treatment, especially in the rural areas. Contemporary
series of patients with PHPT from developed nations are
largely dominated by elderly females with mild to moderate
hypercalcemia and very few with classical symptoms [3],
contrary to the clinical picture seen in developing countries,
especially India. This study was conducted to systematically
review PHPT in India both in the past (before the year 2000)
and the present (after 2000). We also explored the methods
which would possibly change the present trend, so as to
diagnose more cases at an asymptomatic stage in order to
decrease the morbidity and mortality seen in Indian patients
with PHPT.
2.Our Findingsand Observations
There are few publications on PHPT from India when
compared to that of countries like USA, UK, and Australia.
The majority of these publications are case reports, small
case series, and retrospective caseseries ofapproximately100
cases.These publicationslackuniformity inthepresentation,
analysis, interpretation of data, and the speciﬁc information
needed for a meta-analysis and appropriate statistical tests.
Sixty-one publications related to PHPT from various Indian
centers containing data related to 858 PHPT patients were
found and included in this study (1980–2010, retrospective
reviews, case reports). Publications on PHPT from India are2 International Journal of Endocrinology
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Figure 1: Decade wise publications on PHPT from India.
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Figure 2: Publications on PHPT: India versus others.
limited to few select centers [4–10]. The majority (twenty-
one) of publications were from Sanjay Gandhi Postgraduate
Institute of Medical Sciences, Lucknow (SGPGIMS) from
which the data of the ﬁrst 100 cases is included in this
study [4, 5]. Figure 1 shows the decade-wise publications
from India since the ﬁrst publication in 1980 [11]. The
increase in the number of publications on PHPT between
2000–2010 compared to the previous decade is probably
due to the increasing parathyroid awareness among the
physicians; however, the number of publications are far less
when compared to the developed countries. Figure 2 shows
the comparative number of publications from India and the
rest of the world.
3.Demographics
In Indian series, females were commonly aﬀected (1.7:1,
F:M). 71.5%ofthe cases were less than 40yrs ofage whereas
patients from developed nations are diagnosed in the ﬁfth
andsixthdecades.Themeandurationofsymptomswasfrom
84 ± 56.7m o n t h s[ 6, 11–13] which indicate the delay in
diagnosis.
4.ClinicalPresentation
Worldwide, the presentation of PHPT has changed from a
symptomatic to an asymptomatic disease [2]. As a result,
newerguidelinesarebeinglaiddowntodecideonindications
for surgery in asymptomatic disease [15]. In India, however,
asymptomatic presentation is virtually unheard of. Even
the symptomatic disease is picked up late after a series of
management forfractures andrenal stonesby theorthopedic
surgeons and the urologist. Figure 3(a) reveals the advanced
bone disease in onesuch patient. Figure 4 shows a case where
a brown tumor was excised and replaced by prosthesis as
the diagnosis of PHPT was missed. Data from SGPGIMS,
India [4, 5] revealed fractures in 57% of the patients, brown
tumors in 49%, and 27% of patients were crippled (due
to multiple fractures). Combined bone and kidney disease
was seen in 36% of patients, psychiatric symptoms in 38%,
and palpable neck masses in 33%. Bhansali et al. [6]h a v e
observed similar ﬁgures from another premier institute in
India where 67% had bone disease, 48% had fractures, 21%
had stone disease, 23% had psychiatric symptoms and 15%
had peptic ulcer. Among the Indian patients, 5 to 33% had
a clinically palpable parathyroid gland. The data we studied
revealed that symptomatic disease is seen in all the Indian
centers. The overall data related to clinical presentation of
Indian PHPT is shown in Table 1 [6, 11–13, 15–26]. The
disease spectrum in patients from Pakistan [27],Jordan [28],
Turkey [29], Saudi Arabia [30], Hong Kong [31], and Iran
[32] are similar. The reasons for higher incidence of osteitis
ﬁbrosa cystica (OFC) in Indian patients could be due to
Vitamin D(VitD)deﬁciencytogetherwiththefactthatthere
is a delay in seeking medical attention and, therefore, a delay
in diagnosis.
5.Biochemical Parametersand
LocalizationStrategies
At SGPGIMS [5], the patients had a mean serum calcium
levels of 12.3 ± 1.4 (range 10.8–15mg%), serum alka-
line phosphatase (ALP) 1544.3 ± 2077IU/L (range 177–
7240IU/L), and serum Vit D levels of 13.6 ± 6.3( r a n g e6 . 2 –
25ng/mL). Similar biochemical proﬁles have been reported
from other Indian centers (Table 2). Vit D levels in PHPT
have been reported only from few studies from India. Priya
et al. [7] reported Vit D levels of 10.21 ± 5.82ng/mL in their
series of 39 patients. Pradeep et al. [5] also reported similar
low Vit D levelsin patients with PHPT (Table 2). Table 2 also
shows the serum calcium, PTH, and Vit D levelsfrom Indian
centers as compared to a large series of 10,000 cases from
the USA. The levels of serum calcium, PTH, and Vit D were
signiﬁcantly diﬀerent from that ofthe USA(Table 2). Studies
from HongKong[34],Israel [35],andSouthAfrica[36]have
shown that the introduction of autoanalyzers for calcium
detection have enabled them to pick up early disease in older
subjects. Lo et al. [34] observed that in Hong Kong with
introduction of calcium screening, the age of presentation
of PHPT advanced from 45 to 57 years over a three-decade
period of study [37]. However, this was not the case resulting
in early diagnosis of PHPT in India, in spite of increasing
awareness of the disease. Routine health checkups initiated
by a majority of corporate hospitals in India do not include
estimation of serum calcium. Unlike the developed western
nations, the serum calcium, serum parathyroid hormone,
and serum alkaline phosphate levels in patients from IndiaInternational Journal of Endocrinology 3
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Figure 3: (a) Reveals advanced bone disease with fractures of femur (ﬁxed by rod and nails) and (b) the MIBI scan in a patient with
parathyroid adenoma.
Table 1: Clinical characteristics of Indian PHPT and the developed world.
Total number of subjects for which data was
available from India
Percentage aﬀected
(India)
Percentage aﬀected
(developed countries)∗
Bone disease 344 77 5
Fractures 399 40.1 ND
Brown tumors 233 42 3
Renal disease 344 36 15
Proximalmuscle weakness 357 54.1 ND
Pancreatitis 302 15 Nil
Psychiatric symptoms 246 26.4 ND
Asymptomatic disease 246 5.6 >80%
∗Ref [14].
ND: no data.
have been found to be high (Table 2). A majority of Indian
patients also have Vit D deﬁciency [38], which is similar to
reports from countries like Pakistan [27]a n dJ o r d a n[ 28].
OverallPHPThasadvancedclinicalandbiochemicalfeatures
in Indian subjects.
There is a paucity of literature on localization studies in
all the Indian publications; however, the reported data are in
accordancewiththepublishedliteraturefromWesternseries.
Neck ultrasound (USG) has been reported to localize the
adenoma in 65–77% of patients [6, 9, 12]. Methyl isobutyl
isonitrile (MIBI) scan positivity has been reported in 86.9–
100% [12, 17]. Figure 3(b) reveals an MIBI-scan image of a
right inferior parathyroid adenoma in one of our patients.
Thallium-201 Technetium-99 pertechnetate subtraction has
been reported to have a sensitivity of 87–100% [6, 12, 17].
Contrast-enhanced computerized tomography (CECT) of
the neck has a sensitivity ranging from 65% to 93.5% in
localizing parathyroid adenoma [6, 9, 12]. The reported
sensitivity of ultrasound of the neck has been low in
India, which could be due to the absence of a dedicated
parathyroid sinologist. Therefore, the numbers of cases
diagnosed/operatedonarefarlessthanwhatisreportedfrom
the developednations [6, 12, 17, 39].Even thoughThallium-
201Technetium-99 pertechnetate scan and CECTscan of the4 International Journal of Endocrinology
Figure 4: Advanced bone disease (OFC) excised and replaced with humerus prosthesis in a patient with PHPT where the diagnosis was
missed.
Table 2: Comparison of biochemical proﬁle in PHPT from various Indian institutes and a center in USA.
Inst: 1 [4, 5]
(n = 100)
Inst: 2 [8]
(n = 88)
Inst: 3 [6]
(n = 46)
Inst: 4 [7]
(n = 79)
Inst: 5
(n = 15)
(unpublished data)
USA [33]
(n = 10000)
Comparison of
Indian versus USA
study∗
Serum calcium
(2.12–
2.49mmol/l)
3.14 ± 0.41
(2.55–4.24) 2.97 ± 0.25 2.8 ±0.3 3.11 ±0.44
(2.27–4.04)
3.2 ±.31
(2.4–4.1) 2.71 ±.15
P<. 001 (with
institutes 1, 2, and 4)
P<. 01 (with 3 & 5)
Serum PTH
(11–65pg/mL)
1005.8 ±760.3
(66–3250) 623 ± 714 885.3 ±613.2 866.6 ±639.5
(52–3820) 926.2 ±712.5 105.8 ±
48pg/mL
P<. 001 (with
institute 2) P<. 01
( w i t h1 ,3 ,4 ,& 5 )
Serum ALP
(<150IU/L)
1466.5 ± 1547.6
(98–7240) 426 ± 549 NA∗∗ 762.2 ±754.8
(50–4930) 789.1 ±452.3N A
Serum Vit D
(<20ng/mL
Deﬁciency)
11.6 ± 8.74
(2–44) NA NA NA 12.5 ±6.45 22.4 ±9 P<. 001 (with
institutes 1 & 5)
Indian institutes:institute 1: SGPGIMS, Lucknow; institute2: CMC Vellore; institute3: PGIMER Chandigarh; institute 4: KEM Mumbai; institute 5: NMCH
Nellore.
∗Inferential statisticsbetween groups was performed using one-way ANOVA, followed by Newman-Keuls multiplecomparison test.
∗∗NA: Not available.
neck were more commonly used prior to the year 2000 for
localization, these are currentlyreplaced with MIBIand USG
scan [13, 28, 29, 31].
6.SurgicalApproach
Limited data is available on the surgical approach to PHPT
in most of the literature from India. The approach has
ranged from bilateral conventional neck exploration [17]
and unilateral neck exploration [5, 12] to focused parathy-
roidectomy [5]. Focused parathyroidectomy was reported in
38% of cases from one of the centers [5]. Unilateral focused
open exploration has been generally performed only in those
patients who have concordant USG and MIBI ﬁndings.
RecurrentPHPThas ranged fromzero to 4.16%[5, 6,11,13]
and persistent PHPT between zero and 2.7% [5, 6, 11–13].
7.Pathological Features
The striking diﬀerence of PHPT between patients in the
developed countries and India is the weight of the parathy-
roid gland. Study of tumor characteristics in developedInternational Journal of Endocrinology 5
countries showed that the average tumor weight was 2–4gm.
Among Indian patients, the tumor weight ranged from 1.25
to 102gm [6, 9, 11, 18]. In the ten articles which mentioned
thehistopathologyof366patientswith PHPT,theprevalence
of adenoma, hyperplasia, and carcinoma was 89.1%, 6.56%,
and 4.37%, respectively, [5, 6, 9, 11–13, 16, 18, 20]. The
incidence of parathyroid carcinoma causing PHPT in the
various series has been 2.6 to 6% [9, 10, 18]. This is higher
than that observed from developed countries (1%) [1].
8.PostoperativeCourse
There is considerable lack of data from India on the
postoperative course, morbidity, and mortality. These events
havebeen grossly underreported. Postoperative hungry bone
syndrome (HBS) has been observed in 24% to 82% of the
cases [5, 6, 9, 12, 18]. Pradeep et al. [5] reported that, out of
the 100 consecutive PHPT patients operated on, 79 suﬀered
early symptomatic hypocalcemia and 92 had biochemical
hypocalcemia after parathyroidectomy. Maximum fall of
serum calcium levels were observed within a mean period
of 28 hours (range 12–33). Intravenous calcium gluconate
infusion was required for a median period of 6 days (range
3–8 days). Simultaneously, oral calcium carbonate (2g/day)
and calcitriol (1µg/day) was also needed to control the
postoperative hypocalcemia. Associated hypomagnesaemia
has to be corrected in some of the patients since it may
suppress the function of the residual parathyroid tissue,
thereby exacerbating postoperative hypocalcemia [5]. There
seems to be a higher incidence of sepsis in patients with
severe PHPT undergoing parathyroidectomy, though the
cause ofthis isnot yetunderstood. Postoperativepancreatitis
[5, 6, 18] and multiorgan failure are other reported com-
plications. Intravenous calcium infusion used to treat HBS
in the postoperative period has resulted in a high incidence
of thrombophlebitis. Thus, the immediate postoperative
period is turbulent in Indian PHPT patients due to HBS,
postoperativepancreatitis[17,39],sepsis,multiorganfailure,
metabolic disturbances related to the end-stage renal disease,
and thrombophlebitis related to intravenous calcium infu-
sions. In contrast to this, parathyroidectomy in the Western
series is an outpatient procedure with the majority getting
discharged the same day.
The reported mortality rates after parathyroidectomy in
Indian subjects are as high as 7.4% [5, 6, 11]. 50% of the
mortality has been due to end-stage renal disease, 16.6% due
to metastasis [40], and others due to sepsis and unknown
causes.
9.Long-TermFollowup
Data on long-term followup of patients from India with
advanced PHPT is scarce. Recently, the long-term fol-
lowupafter parathyroidectomy (2–13yrs) was reported from
SGPGIMS [5]. According to this study, ALP normalized
within 4 to 18 months and healing of the cortical bones
occurredin 2–7months. Ata median followup of3years, the
gain in bone mineral density (BMD) was 48.99% at the hip,
48.66% at the lumbarspine, and 39.84%at the forearm. This
gain was more in the Vit D suﬃcient group when compared
to the patients who were Vit D deﬁcient preoperatively and
continued to be so after parathyroidectomy [5]. Similar
healing of bone lesions was noticed by Bhansali et al. [6]
(mean followup 3.82 ± 2.96yrs). Among the patients with
renal stones, 68.7% did not have any further episodes of
renal colic [5]. However, the mortality was more in the
patients who had nephrocalcinosis/hydronephrosis. Only
one study has assessed the neuropsychiatric manifestations
in Indian PHPT and their recovery to date [21]. This study
showed signiﬁcant improvement in the Comprehensive
Psychopathological Rating Scale at six weeks after parathy-
roidectomy and no impairment was noted in memory and
intelligence. Anemia and marrow ﬁbrosis improved after
curative parathyroidectomy in a series of 28 patients at
three months of followup [22]. The incidence of recurrent
hyperparathyroidism ranged from zero to 4.16% in diﬀerent
series [5, 6, 11, 13]. Postoperative persistent disease has been
n o t e di nu pt o2 . 7 %o fp a t i e n t s[ 5, 6, 11–13].
10.Summary
In conclusion, a majority of patients diagnosed with PHPT
in India have symptomatic disease. The mean calcium, PTH,
and alkaline phosphate levels are high with low Vit D levels.
Vit D deﬁciency contributes to the severity of bone disease.
HBS in the postoperative period necessitates intravenous
calcium supplements and prolonged hospital stay, resulting
in higher morbidity.
Patients might beneﬁt from early diagnosis of mild and
asymptomatic PHPTonlyifmoreeﬀortsaretakentoidentify
these cases. For this to be possible, eﬀorts are needed to
incorporate calcium screening in the routine health check-
ups. The increasing parathyroid awareness among physicians
as evidenced by the increase in the number of publications
on PHPT will help in diagnosing more cases. Similarly, the
introduction of courses (DM and MCh) in endocrinology
and endocrine surgery by the Indian Medical Council will
increase the awareness among practicing clinicians in the
area of endocrinology, which in turn will lead to better
diagnosis of PHPT. Awareness among the orthopaedicians,
urologists, nephrologists, and rheumatologists in India also
has to increase since in India the majority of patients
are initially diagnosed by them. We also see a need for
organizing continuingmedicaleducationprogramstargeting
these specialists and general practitioners, especially by those
centers who are managing parathyroid diseases. Until then,
patients with PHPT in India will continue to be diagnosed
late and present with ﬂorid manifestations.
Appendix
For the present study, PubMed search for publications
on PHPT from India was performed with the key words
“hyperparathyroidism, India, and names of the individual
centers.” Indian data available on the demographics, clinical
presentation, localization, operative approaches, postoper-
ative course, and the long-term followup were analyzed.6 International Journal of Endocrinology
Information on PHPT was also obtained from the internet,
conference proceedings, presentations, and personal com-
munications with other centers in India. A major limitation
of this literature review on PHPT from India has been the
lack of uniformity of data provided in the diﬀerent studies.
Due to this, the statistical tests could not be applied to a
major part of the data. Data has been presented as means ±
SD,median, and ranges. Inferential statistics between groups
(Table2)wasperformed using one-wayANOVA,followedby
Newman-Keuls multiple comparison test.
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